About
Contact & Profiles
Research Areas
- Spinal Cord Injury Research
- Stroke Rehabilitation and Recovery
- Acute Lymphoblastic Leukemia research
- Muscle activation and electromyography studies
- Protein Degradation and Inhibitors
- Cancer Genomics and Diagnostics
- Melanoma and MAPK Pathways
- Pancreatitis Pathology and Treatment
- Pancreatic and Hepatic Oncology Research
- Cancer therapeutics and mechanisms
- Genetics, Bioinformatics, and Biomedical Research
- Gastrointestinal disorders and treatments
University of New Mexico
1998-2024
10.1038/s41594-019-0358-z
article
EN
Nature Structural & Molecular Biology
2020-01-01
10.1038/sj.sc.3100698
article
EN
Spinal Cord
1998-11-01
10.3928/00904481-20160115-01
article
EN
Pediatric Annals
2016-02-01
10.1182/blood-2024-212205
article
EN
Blood
2024-11-05
10.1182/blood-2023-191235
article
EN
Blood
2023-11-02
10.1097/01253086-199822050-00052
article
EN
Neurology Report
1998-01-01
Abstract Drug resistant mutations that arise in therapeutic targets often limit clinical responses. However, the discovery of such has historically been performed one gene or mutation at a time, over decades experimental and testing, limiting our understanding conserved mechanisms drug resistance. We hypothesized deep mutational scanning canonical kinases may expedite this process identify novel elements cause resistance when mutated (similar to well-studied “Gatekeeper” residue). To test...
10.1158/1538-7445.am2018-1815
article
EN
Cancer Research
2018-07-01
Coming Soon ...